We next attempted to elucidate the mechanisms by which the differential activation of p53 by the inhibition of MDM2 in glioma stem cells and non-stem glioma cells resulted in the preferential activation of the apoptotic program in the former over the latter. The gene discussed is TP53; the disease is central nervous system cancer.